Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
AJR. American Journal of Roentgenology|April 18, 2002
Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhageMikiya Kitamoto, Michio Imamura, Koji Kamada, et al.
Journal of Gastroenterology and Hepatology|November 27, 2008
Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: a randomized clinical trialTomokazu Kawaoka, Yoshiiku Kawakami, Keiji Tsuji, et al.
Journal of Gastroenterology|August 19, 2007
The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliterationNobuhiko Hiraga, Hiroshi Aikata, Shintaro Takaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 4, 2009
Predicting the response to 48-week combination therapy with peginterferon alpha-2b plus ribavirin from the estimated HCV RNA load index after negative serum change in genotype 1b hepatitis C patientsKeiji Tsuji, Yoshiiku Kawakami, Shiomi Aimitsu, et al.
AJR. American Journal of Roentgenology|September 23, 2003
Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolizationMikiya Kitamoto, Masaru Imagawa, Hiroyasu Yamada, et al.
Intervirology|February 7, 2008
Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled trialShintaro Takaki, Yoshiiku Kawakami, Michio Imamura, et al.
Journal of Gastroenterology and Hepatology|April 10, 2008
Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapySoocheol Jeong, Yoshiiku Kawakami, Mikiya Kitamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2010
Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systemsTomokazu Kawaoka, Hiroshi Aikata, Shintaro Takaki, et al.
Journal of Gastroenterology and Hepatology|August 6, 2014
Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysisSatoe Yokoyama, Yoshiiku Kawakami, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 16, 2012
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patientsMasahiko Koda, Yoshikazu Murawaki, Yasuaki Hirooka, et al.
Pageof 3